Overview

Study Evaluating Multiple Oral Doses of PPM-204 in Healthy Japanese Male Subjects

Status:
Completed

Trial end date:
2007-03-01

Target enrollment:

Participant gender:

Summary

A study evaluating the safety and pharmacokinetics of multiple oral doses of an investigational oral diabetic agent when given to healthy Japanese male volunteers.

Phase:

Phase 1

Details

Lead Sponsor:

Wyeth is now a wholly owned subsidiary of Pfizer